நீல் சாலமன்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீல் சாலமன்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீல் சாலமன்கள் Today - Breaking & Trending Today

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of . ....

United States , United Kingdom , Neil Solomons , Rob Huizinga , Glenn Schulman , Peter Greenleaf , Aurinia Pharmaceuticals Inc , Exchange Commission Electronic Document Gathering , Drug Administration , Riptide Bioscience Inc , Thunderbolt Pharma Inc , Investor Relations Corporate Communications , Chief Executive Officer , Recombinant Fc Protein Targeting , Thunderbolt Pharma , B Cell Activating Factor , Proliferation Inducing Ligand , United State Food , Chief Medical Officer , Riptide Bioscience , Executive Vice President , British Columbia , Annual Report , Canadian Securities Administrator System , Electronic Document Analysis , Exchange Commission ,

Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the Aurinia Year-end 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is recorded. It s now my pleasure to turn the call over to Glenn Schulman, Senior Vice President, Investor Relations. Please go ahead, sir.
Glenn Schulman
Senior Vice President, Corporate Communications and Investor Relations
Thank you, Kevin, and good afternoon, everyone. I m pleased to welcome you to today s call discussing Aurinia s fourth quarter and year-end financial results. Joining me on the call this afternoon are Peter Greenleaf, President and CEO of Aurinia; Neil Solomons, our Chief Medical Officer; Max Colao, Chief Commercial Officer; and Joe Miller, our Chief Financial Officer. This afternoon, just after 4:00 p.m., we issued a press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com and has been filed on a Form 8-K ....

United States , Switzerland General , Peter Greenleaf , Glenn Schulman , Maury Raycroft , Neil Solomons , Max Colao , Alethia Young , Justin Kim , Emily Cantor Fitzgerald , Joe Miller , Otsuka Pharmaceuticals , Aurinia Pharmaceuticals Inc , Aurinia Alliance , Maurice Thomas Raycroft Jefferies , Exchange Commission , Cowen Company , Justin Alexander Kim Oppenheimer Co , Cantor Fitzgerald , Corporate Communications , Devices Agency , Company Analyst , Aurinia Year End , Results Conference , Senior Vice President , Vice President ,

Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences


Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences
Aurinia Pharmaceuticals Inc. today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner: H.C. Wainwright Virtual BioConnect 2021 Conference. On-demand fireside chat available beginning Monday, January 11, 2021 at 6:00 a.m. EST; Scott Gottlieb, M.D. Hosts a Panel …
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner: ....

United States , United Kingdom , Neil Solomons , Scott Gottlieb , Hc Wainwright Bioconnect , Aurinia Pharmaceuticals Inc , Aurinia Pharmaceuticals , Virtual Bioconnect , Panel Discussion , Clinical Trials , Chief Medical Officer , Annual Healthcare , British Columbia , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நீல் சாலமன்கள் , ஸ்காட் காட்‌லீப் , ஒரினிய மருந்துகள் இன்க் , ஒரினிய மருந்துகள் , குழு கலந்துரையாடல் , மருத்துவ சோதனைகள் , தலைமை மருத்துவ அதிகாரி , ஆண்டு சுகாதாரம் , பிரிட்டிஷ் கொலம்பியா ,